You just read:

Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™

News provided by

Amylin Pharmaceuticals, Inc. , Eli Lilly and Company

Oct 20, 2010, 02:04 ET